1
|
Caothien R, Yu C, Tam L, Newman R, Nakao B, Alcantar T, Bacarro N, Reyes J, Pham A, Roose-Girma M. Accelerated embryonic stem cell screening with a highly efficient genotyping pipeline. Mol Biol Rep 2022; 49:3281-3288. [PMID: 35107736 DOI: 10.1007/s11033-022-07165-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2021] [Accepted: 01/19/2022] [Indexed: 12/01/2022]
Abstract
INTRODUCTION Gene targeting in mouse ES cells replaces or modifies genes of interest; conditional alleles, reporter knock-ins, and amino acid changes are common examples of how gene targeting is used. For example, enhanced green fluorescent protein or Cre recombinase is placed under the control of endogenous genes to define promoter expression patterns. METHODS AND RESULTS The most important step in the process is to demonstrate that a gene targeting vector is correctly integrated in the genome at the desired chromosomal location. The rapid identification of correctly targeted ES cell clones is facilitated by proper targeting vector construction, rapid screening procedures, and advances in cell culture. Here, we optimized and functionally linked magnetic activated cell sorting (MACS) technology as well as multiplex droplet digital PCR (ddPCR) to our ES cell screening process to achieve a greater than 60% assurance that ES clones are correctly targeted. In a further refinement of the process, drug selection cassettes are removed from ES cells with adenovirus technology. We describe this improved workflow and illustrate the reduction in time between therapeutic target identification and experimental validation. CONCLUSION In sum, we describe a novel and effective implementation of ddPCR, multiMACS, and adenovirus recombinase into a streamlined screening workflow that significantly reduces timelines for gene targeting in mouse ES cells.
Collapse
Affiliation(s)
- Roger Caothien
- Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA
| | - Charles Yu
- Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA
| | - Lucinda Tam
- Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA
| | - Robert Newman
- Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA
| | - Brian Nakao
- Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA
| | - Tuija Alcantar
- Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA
| | - Natasha Bacarro
- Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA
| | - Juan Reyes
- Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA
| | - Anna Pham
- Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA
| | - Merone Roose-Girma
- Department of Molecular Biology, Genentech, Inc., South San Francisco, CA, USA.
| |
Collapse
|
2
|
Abstract
A transgenic mouse carries within its genome an artificial DNA construct (transgene) that is deliberately introduced by an experimentalist. These animals are widely used to understand gene function and protein function. When addressing the history of transgenic mouse technology, it is apparent that a number of basic science research areas laid the groundwork for success. These include reproductive science, genetics and molecular biology, and micromanipulation and microscopy equipment. From reproductive physiology came applications on how to optimize mouse breeding, how to superovulate mice to produce zygotes for DNA microinjection or preimplantation embryos for combination with embryonic stem (ES) cells, and how to return zygotes and embryos to a pseudopregnant surrogate dam for gestation and birth. From developmental biology, it was learned how to micromanipulate embryos for morula aggregation and blastocyst microinjection and how to establish germline competent ES cells. From genetics came the foundational principles governing the inheritance of genes, the interactions of gene products, and an understanding of the phenotypic consequences of genetic mutations. From molecular biology came a panoply of tools and reagents that are used to clone DNA transgenes, to detect the presence of transgenes, to assess gene expression by measuring transcription, and to detect proteins in cells and tissues. Technical advances in light microscopes, micromanipulators, micropipette pullers, and ancillary equipment made it possible for experimentalists to insert thin glass needles into zygotes or embryos under controlled conditions to inject DNA solutions or ES cells. To fully discuss the breadth of contributions of these numerous scientific disciplines to a comprehensive history of transgenic science is beyond the scope of this work. Examples will be used to illustrate scientific developments central to the foundation of transgenic technology and that are in use today.
Collapse
Affiliation(s)
- Thomas L Saunders
- Transgenic Animal Model Core, University of Michigan Medical School, Ann Arbor, MI, USA.
- Division of Genetic Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
| |
Collapse
|